Appendix 4D and Half Year Report

24 February 2017

Your Directors present their report on the Company and its controlled entities for the half year ended 31 December 2016.

The result from ordinary activities attributable to CLINUVEL PHARMACEUTICALS LIMITED for the half year was a net profit of $2,522,519, representing a 177% improvement to the financial result for the same period last year (a net loss of $3,261,046).

Download PDF for more

We use cookies to give you the best experience.